dc.contributor |
Reykjavík University (RU) |
dc.contributor |
Háskólinn í Reykjavík (HR) |
dc.contributor.author |
Young, Susan |
dc.contributor.author |
Asherson, Philip |
dc.contributor.author |
Lloyd, Tony |
dc.contributor.author |
Absoud, Michael |
dc.contributor.author |
Arif, Muhammad |
dc.contributor.author |
Colley, William Andrew |
dc.contributor.author |
Cortese, Samuele |
dc.contributor.author |
Cubbin, Sally |
dc.contributor.author |
Doyle, Nancy |
dc.contributor.author |
Morua, Susan Dunn |
dc.contributor.author |
Ferreira-Lay, Philip |
dc.contributor.author |
Gudjonsson, Gisli |
dc.contributor.author |
Ivens, Valerie |
dc.contributor.author |
Jarvis, Christine |
dc.contributor.author |
Lewis, Alexandra |
dc.contributor.author |
Mason, Peter |
dc.contributor.author |
Newlove-Delgado, Tamsin |
dc.contributor.author |
Pitts, Mark |
dc.contributor.author |
Read, Helen |
dc.contributor.author |
van Rensburg, Kobus |
dc.contributor.author |
Zoritch, Bozhena |
dc.contributor.author |
Skirrow, Caroline |
dc.date.accessioned |
2021-07-02T10:50:15Z |
dc.date.available |
2021-07-02T10:50:15Z |
dc.date.issued |
2021-03-19 |
dc.identifier.citation |
Young, S., Asherson, P., Lloyd, T., Absoud, M., Arif, M., Colley, W. A., Cortese, S., Cubbin, S., Doyle, N., Morua, S. D., Ferreira-Lay, P., Gudjonsson, G., Ivens, V., Jarvis, C., Lewis, A., Mason, P., Newlove-Delgado, T., Pitts, M., Read, H., … Skirrow, C. (2021). Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.649399 |
dc.identifier.issn |
1664-0640 (eISSN) |
dc.identifier.uri |
https://hdl.handle.net/20.500.11815/2644 |
dc.description |
Publisher's version (útgefin grein) |
dc.description.abstract |
Background: Despite evidence-based national guidelines for ADHD in the
United Kingdom (UK), ADHD is under-identified, under-diagnosed, and under-treated.
Many seeking help for ADHD face prejudice, long waiting lists, and patchy or unavailable
services, and are turning to service-user support groups and/or private healthcare
for help.
Methods: A group of UK experts representing clinical and healthcare providers
from public and private healthcare, academia, ADHD patient groups, educational,
and occupational specialists, met to discuss shortfalls in ADHD service provision in
the UK. Discussions explored causes of under-diagnosis, examined biases operating
across referral, diagnosis and treatment, together with recommendations for resolving
these matters.
Young et al. Failure of ADHD Healthcare Provision
Results: Cultural and structural barriers operate at all levels of the healthcare system,
resulting in a de-prioritization of ADHD. Services for ADHD are insufficient in many
regions, and problems with service provision have intensified as a result of the response
to the COVID-19 pandemic. Research has established a range of adverse outcomes of
untreated ADHD, and associated long-term personal, social, health and economic costs
are high. The consensus group called for training of professionals who come into contact
with people with ADHD, increased funding, commissioning and monitoring to improve
service provision, and streamlined communication between health services to support
better outcomes for people with ADHD.
Conclusions: Evidence-based national clinical guidelines for ADHD are not being met.
People with ADHD should have access to healthcare free from discrimination, and in
line with their legal rights. UK Governments and clinical and regulatory bodies must act
urgently on this important public health issue. |
dc.description.sponsorship |
The meeting was jointly funded by the ADHD Foundation,
the UK Adult ADHD Network (UKAAN), and the UK ADHD
Partnership (UKAP). Other than reimbursement of travel
expenses to attend the meeting, none of the authors received
any financial compensation for attending the meeting or writing
the manuscript, aside from CS who was remunerated for her
time. PA was supported by NIHR Biomedical Research Center
for Mental Health, NIHR/MRC (14/23/17) and NIHR senior
investigator award (NF-SI-0616-10040). TN-D was funded by an
NIHR Advanced Fellowship (NIHR300056). The views expressed
in this publication are those of the authors and not necessarily
those of the NHS, the National Institute for Health Research or
the Department of Health and Social Care. |
dc.format.extent |
Article 649399 |
dc.language.iso |
en |
dc.publisher |
Frontiers Media SA |
dc.relation.ispartofseries |
Frontiers in Psychiatry;12 |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.subject |
Psychiatry and Mental health |
dc.subject |
ADHD |
dc.subject |
Geðheilsa |
dc.subject |
Service provision |
dc.subject |
Healthcare commissioning |
dc.subject |
Assessment |
dc.subject |
Treatment |
dc.subject |
Meðferð |
dc.subject |
Sálfræði |
dc.title |
Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement |
dc.type |
info:eu-repo/semantics/article |
dcterms.license |
Attribution 4.0 International (CC BY 4.0) |
dc.description.version |
Peer Reviewed (ritrýnd grein) |
dc.identifier.journal |
Frontiers in Psychiatry |
dc.identifier.doi |
https://doi.org/10.3389/fpsyt.2021.649399 |
dc.relation.url |
https://www.frontiersin.org/articles/10.3389/fpsyt.2021.649399/full |
dc.contributor.department |
Department of Psychology (RU) |
dc.contributor.department |
Sálfræðideild (HR) |
dc.contributor.school |
School of Social Sciences (RU) |
dc.contributor.school |
Samfélagssvið (HR) |